iBio, Inc. has introduced cGMP sterile fill-finish capabilities for pharmaceutical products, including monoclonal antibodies, viral vectors, and other biologics, for preclinical and clinical stage programs. The operation is housed in the company’s 135,000 sq.-ft. manufacturing facility in Bryan, TX. The sterile liquid fill-finish operation will incorporate in-line labeling, allowing serialization of vials as they are filled. Initial capacity supports 100 – 2,500 vials runs, with plans to expa...